Drupal.behaviors.print = function(context) {window.print();window.close();}>
Dx Focus: Asuragen's RNARetain; Quest's Renal Transplant Test; Meridian's Illumigene GBS Dx
March 22, 2012
Dx Focus: Asuragen's RNARetain; Quest's Renal Transplant Test; Meridian's Illumigene GBS Dx
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Meridian Bioscience Reports 13 Percent Spike in Q1 Revenues Driven by Growth in Illumigene Products
January 24, 2013 / PCR Insider
Asuragen Using NICHHD Grant to Adapt Fragile X MDx Assay for Newborn Screening
October 6, 2011 / PCR Insider
Quest Pulls Ahead in Fragile X Test Race with NY State DoH Approval
July 29, 2010 / PCR Insider
PCR-Based Fragile X Tests Abound, but Will There be a Market?
May 20, 2010 / PCR Insider
Q&A: Jamie Platt of Quest Dx's Nichols Institute on Sample Prep in Clinical Sequencing
May 9, 2013 / PCR Insider